These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22935070)

  • 21. Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
    Altinoz MA; Topcu G; Hacimuftuoglu A; Ozpinar A; Ozpinar A; Hacker E; Elmaci İ
    Neurochem Res; 2019 Aug; 44(8):1796-1806. PubMed ID: 31292803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into the Tubulin-Targeted Anticancer Potential of Noscapine and its Structural Analogs.
    Kumar S; Sagar B; Gaur A; Shukla S; Pandey E; Gulati S
    Anticancer Agents Med Chem; 2023; 23(6):624-641. PubMed ID: 35927808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged antitussive action of a resin-bound noscapine preparation.
    Wulff O
    J Pharm Sci; 1965 Jul; 54(7):1058-60. PubMed ID: 5862522
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological properties of noscapine].
    Sukhinina GP
    Farmakol Toksikol; 1968; 31(6):702-5. PubMed ID: 4388890
    [No Abstract]   [Full Text] [Related]  

  • 26. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noscapine comes of age.
    Chen X; Dang TT; Facchini PJ
    Phytochemistry; 2015 Mar; 111():7-13. PubMed ID: 25583437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents.
    Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK
    J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy.
    Madan J; Gundala SR; Kasetti Y; Bharatam PV; Aneja R; Katyal A; Jain UK
    Anticancer Drugs; 2014 Jul; 25(6):704-16. PubMed ID: 24642711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro.
    Yang ZR; Liu M; Peng XL; Lei XF; Zhang JX; Dong WG
    Biochem Biophys Res Commun; 2012 May; 421(3):627-33. PubMed ID: 22546556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of the prenatal hypoxic-ischemic brain edema with noscapine.
    Mahmoudian M; Siadatpour Z; Ziai SA; Mehrpour M; Benaissa F; Nobakht M
    Acta Physiol Hung; 2003; 90(4):313-8. PubMed ID: 14708873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
    Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
    Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.
    Henary M; Narayana L; Ahad S; Gundala SR; Mukkavilli R; Sharma V; Owens EA; Yadav Y; Nagaraju M; Hamelberg D; Tandon V; Panda D; Aneja R
    Biochem Pharmacol; 2014 Nov; 92(2):192-205. PubMed ID: 25124704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of L-tryptophan on the effects of antitussives.
    Kamei J; Mori T; Kasuya Y
    J Pharmacobiodyn; 1990 Apr; 13(4):231-7. PubMed ID: 2384857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained activation of p34(cdc2) is required for noscapine-induced apoptosis.
    Ye K; Zhou J; Landen JW; Bradbury EM; Joshi HC
    J Biol Chem; 2001 Dec; 276(50):46697-700. PubMed ID: 11679575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanosolvated microtubule-modulating chemotherapeutics: a case-to-case study.
    Jain V; Jain B; Tiwari P; Saini J; Jain UK; Pandey RS; Kumar M; Katare OP; Chandra R; Madan J
    Anticancer Drugs; 2013 Apr; 24(4):327-36. PubMed ID: 23411683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
    Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efffect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig.
    Mahmoudian M; Mojaverian N
    Acta Physiol Hung; 2001; 88(3-4):231-7. PubMed ID: 12162581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents.
    DeBono A; Capuano B; Scammells PJ
    J Med Chem; 2015 Aug; 58(15):5699-727. PubMed ID: 25811651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.